In HER2-positive breast cancer, IL-6 can also induce the production and maintenance of breast cancer stem cells (CSCs) through nuclear factor kappa-B (NF-κB) and STAT3 signaling pathways, then promoting tumor progression [31]. The gene discussed is STAT3; the disease is breast carcinoma.